We are excited to invite you to an exclusive webinar sharing the high-level insights from the International Scientific Exchange (ISE) 2.0 held at the TÜV SÜD.
While sterilisation is a cornerstone of medical device safety, the industry faces a significant slowdown in innovation. Despite the existence of novel methods, widespread implementation is often stalled by material compatibility concerns, a lack of international standardisation, and the complex regulatory burden associated with transitioning legacy products.
To address these systemic challenges, we are hosting an exclusive webinar session recaps the high-level collaboration between global industry leaders and TÜV SÜD held in March 2025.
This webinar will present the essence of the discussions held by industry at the event:
- The current progress in novel sterilisation modalities industry dynamics in 2026
- Regulatory impacts and sustainability considerations
- Challenges for testing and documenting new sterilisation methods for regulatory submission
- What’s next: publications and breakout groups focused on material science, biocompatibility, packaging and sterilisation
Webinar details
- Date: 12 March 2026, Thursday
- Time: 10am EDT, 3pm CET
- Language: English
Speakers
John Logar | Johnson & Johnson MQSAFellow, Sterility Assurance Co-Lead – Kilmer Community John Logar is a Sterility Assurance Fellow at J&J with over 30 years’experience in healthcare sterilization. He is a strategic visionary leader and industry recognized expert who is passionate about delivering sterile products and solutions that change people’s lives. |
Jan Havel | TÜV SÜDGlobal Director Non-Active Medical Devices Generic Expertise Group Dr. Havel is the Global Director of a team of international experts in the field of sterilization-, packaging design- and sterile packaging process validation, validation of the design of reprocessing instructions for medical devices and of experts in the field of biological and microbiological safety of medical devices. In his 19 years working for the Notified Body he was involved in standardization (ASTM F02) and common specifications definition in context of NAKI and the new MDR. |
Thierry Wagner | DuPontGlobal Sustainability, Regulatory and Product Stewardship Leader Thierry Wagner has spent over 37 years working for DuPont and currently as Global Sustainability, Regulatory and Product Stewardship Leader – Tyvek® located in Luxembourg. He is convenor of ISO/TC 198/WG7 “Sterilization of Health Care Products—Packaging” and of CEN/ TC 102/WG4 “Sterilizers and associated equipment for processing of medical devices – Packaging”, past chairman of the Sterile Barrier Association (SBA), currently SBA director and regulatory committee chair. Thierry published 2 book chapters on healthcare packaging and is a regular speaker at events and conferences on medical and pharmaceutical packaging. |
Aaron DeMent | SterigenicsVP of Sterilization Technology |
Jami McLaren | Johnson & JohnsonSenior Principal Engineer, Gas Sterilization Jami McLaren is responsible for driving strategy around gas-based sterilization modalities for Johnson and Johnson. Jami is an active participant of several AAMI sterilization working groups, co-lead of the Kilmer |
Jordan Montgomery | MedtronicDistinguished Engineer | Technical Fellow | Medtronic Package Engineering Jordan Montgomery is a packaging engineer and Technical Fellow at Medtronic with over 2 decades of experience in package design. Jordan represents the United States as a delegate to the ISO Packaging Working Group where he has been active in the ISO 11607 series and also a participating member of ASTM. |
Randy Eveland | STERIS | Reprocessing GroupSenior Principal Scientist Dr. Eveland is a Senior Principal Scientist at STERIS with 25 years’ experience developing sterilisation and disinfection methods for medical devices. His primary focus has been low-temperature vaporised hydrogen peroxide sterilisers and steriliser accessories. |
David Opie | NoxilizerChief Technology Officer David Opie,Ph.D. has spent more than 15 years developing the NO2 sterilisation technology. Prior to joining Noxilizer he worked for several medical device companies. |
Emily Lorcheim | ClorDiSysVP, Sterilization Technologies Emily Lorcheim leads the Kilmer Chlorine Dioxide Modality Group, working to accelerate acceptance of alternative sterilization modalities. Additionally, Emily is part of standards development with AAMI and participates in several Working Groups, as well as is involved with various ASTM committees. |
Christina Ankjærgaard | DTU Health TechnologyTechnical University of Denmark Senior Scientist and Head of Risø High Dose Reference Laboratory Christina Ankjærgaard, Ph.D., is a Senior Scientist and Head of the Dosimetry Section at the Technical University of Denmark (DTU). She has more than 20 years of experience in ionizing radiation dosimetry across |
Erik Haghedooren | SterigenicsSenior Director, New Technologies and Research & Development Dr. Haghedooren is a Senior Director at Sterigenics with over 15 years of experience in the pharmaceutical and medical device industries. His background spans Quality, Regulatory Affairs, Laboratory Operations, Validation, and Operational Leadership roles. In recent years, his focus has been on the execution and optimization of core gas sterilization technologies, including ethylene oxide, as well as the development and commercialization of innovative sterilization solutions such as nitrogen dioxide. |
